This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Pietsch,_M
There is no page with the exact title "Pietsch,_M". The search results for "Pietsch,_M" are displayed below. You can create a page titled Pietsch,_M (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below 16 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Pietsch M (40 bytes)
1: List of pages with the keyword Pietsch M - Category:Pietsch, M (41 bytes)
1: List of pages with the keyword Pietsch, M
Page text matches
- 4ib5 (5,134 bytes)
15: ...uerra B, Neundorf I, Bopp B, Issinger OG, Jose J, Pietsch M, Niefind K ACS Chem Biol. 2013 Mar 18. PMID:234...
35: [[Category: Pietsch M]] - Category:Pietsch M (40 bytes)
1: List of pages with the keyword Pietsch M - 4q2k (3,188 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...hibitors with reduced Peptide character.,Chua KC, Pietsch M, Zhang X, Hautmann S, Chan HY, Bruning JB, Guts... - Category:Pietsch, M (41 bytes)
1: List of pages with the keyword Pietsch, M - 5tz2 (4,654 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...ability of anti-human CD47 monoclonal antibodies.,Pietsch EC, Dong J, Cardoso R, Zhang X, Chin D, Hawkins R... - 5tzt (4,712 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...ability of anti-human CD47 monoclonal antibodies.,Pietsch EC, Dong J, Cardoso R, Zhang X, Chin D, Hawkins R... - 6f5m (5,553 bytes)
18: ...with an S2' site binding inhibitor.,Hochscherf J, Pietsch M, Tieu W, Kuan K, Abell AD, Gutschow M, Niefind ...
35: [[Category: Pietsch, M]] - 6spw (5,472 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...ubstrate inhibitors targeting protein kinase CK2.,Pietsch M, Viht K, Schnitzler A, Ekambaram R, Steinkruger... - 6spx (5,434 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...ubstrate inhibitors targeting protein kinase CK2.,Pietsch M, Viht K, Schnitzler A, Ekambaram R, Steinkruger... - 6tbe (3,500 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...rface.,Hartmann M, Huber J, Kramer JS, Heering J, Pietsch L, Stark H, Odadzic D, Bischoff I, Furst R, Schro... - 6tlb (3,539 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
16: ...uk K, Zurborg A, Sohnchen C, Liffner B, Wilcke L, Pietsch E, Strauss J, Jeffries CM, Svergun DI, Wilson DW,... - 8dhf (4,160 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
18: ...reatment of Acute Myelogenous Leukemia.,Cisar JS, Pietsch C, DeRatt LG, Jacoby E, Kazmi F, Keohane C, Legen... - 8dhg (4,166 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
18: ...reatment of Acute Myelogenous Leukemia.,Cisar JS, Pietsch C, DeRatt LG, Jacoby E, Kazmi F, Keohane C, Legen... - 8dhh (4,176 bytes)
6: ...r id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="...
18: ...reatment of Acute Myelogenous Leukemia.,Cisar JS, Pietsch C, DeRatt LG, Jacoby E, Kazmi F, Keohane C, Legen...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
